| This week's sponsor is Pfizer CentreOne. | | | |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, September 18, 2018 Novo Nordisk is laying off 400 employees in China and Denmark as part of a reorganization of its R&D department. The reshuffle comes as the company seeks to build a pipeline of chronic disease drugs capable of mitigating the pressures faced by its core diabetes business. |
|
|
Top Stories Of The Week Tuesday, September 18, 2018 After a series of scandals, management has decided it’s high time it instilled some new measures aimed at upholding internal standards and repairing its reputation, including tying its sales representatives' bonuses to ethical behavior review. Tuesday, September 18, 2018 Another scientist who previously worked for GlaxoSmithKline has admitted conspiring to steal trade secrets from the company and pass them on to a Chinese rival. Monday, September 17, 2018 Scientists at Genentech have perfected a naturally occurring molecule so it can penetrate E. coli and other Gram-negative bacteria. The discovery could lead to a whole new class of antibiotics. Monday, September 17, 2018 Cancer blood test company Epic Sciences brought in $52 million to advance its suite of liquid biopsies, which use computer vision and machine learning to identify circulating tumor cells while characterizing the body’s immune response at the same time, toward regulatory approval. Tuesday, September 18, 2018 A California lawsuit alleges that AbbVie grew Humira sales through kickbacks and nurse "ambassadors" at the expense of patient safety. Tuesday, September 18, 2018 Move over, Siri and Alexa: There’s a new voice in town. Meet Sophia, Novo Nordisk’s first chatbot built specifically for people with diabetes. Wednesday, September 19, 2018 Gene-editing specialist Horizon Discovery has entered into a collaboration with AstraZeneca as part of the pharma giant’s efforts to set up a genomics discovery platform. Monday, September 17, 2018 The race is on for a next-generation pneumococcal vaccine. Merck is already in phase 3 testing with its program, and Pfizer's CFO said his company is "all in" on advancing its shot. Monday, September 17, 2018 Drug manufacturers were shaking off the remnants of Hurricane Florence on Monday after the dangers from the “monstrous” storm morphed into hazardous flooding. Resources Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Veeva A top 20 pharma and growing biotech re-engineer regulatory processes. Sponsored by: Sciformix Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be! Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: Patheon, part of Thermo Fisher Scientific When developing a parenteral, pharmaceutical scientists are faced with a variety of choices – choices that can be conflicting or present differing advantages. Sponsored by: Baxter Baxter BioPharma Solutions’ whitepaper offers a method to address the challenges of tech transfer for lyophilized products from lab-scale to commercial-scale. Sponsored by: Blue Matter A whitepaper outlining the key commercial challenges facing rare disease products, and how biopharmaceutical companies can overcome them. Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Health Strategies Group The window of market exclusivity continues to narrow dramatically in the global marketplace. Given this demanding environment, your global market access team faces increasing urgency to get the value proposition right at the time of launch. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. | 